Invasive Pituitary Adenoma-Derived Tumor-Associated Fibroblasts Promote Tumor Progression both In Vitro and In Vivo

Abstract

Tumor-associated fibroblasts are the most abundant population in tumor stroma and impact on tumor initiation and progression. However, the biological function of tumor-associated fibroblasts in pituitary adenomas has not been fully elucidated to date. So, this study aims to clarify the function and significance of primary cultured pituitary adenoma-derived tumor-associated fibroblasts on rat pituitary adenoma cells. We identified primary cultured tumor-associated fibroblasts and normal fibroblasts based on the expression of α-smooth muscle actin as well as morphology. Furthermore, we investigated cell biological influences on rat pituitary adenoma cells through indirectly co-culturing tumor-associated fibroblasts with GH3 cells and subcutaneous xenograft model. All sorts of fibroblasts showed positive staining for α-smooth muscle actin. But α-smooth muscle actin and vascular endothelial growth factor highly expressed in invasive pituitary adenoma-derived tumor-associated fibroblasts compared to non-invasive pituitary adenoma-derived tumor-associated fibroblasts and normal fibroblasts. Besides, invasive pituitary adenoma-derived tumor-associated fibroblasts promoted the proliferation of GH3 cells in vitro as well as tumor growth in vivo. Finally, vascular endothelial growth factor was highly expressed in tumor specimens co-injected with invasive pituitary adenoma-derived tumor-associated fibroblasts. Our results suggested that invasive pituitary adenoma-derived tumor-associated fibroblasts displayed apparent growth promotion effects on rat pituitary cells both in vitro and in vivo accompanied by over-expression of vascular endothelial growth factor in invasive pituitary adenoma-derived tumor-associated fibroblasts and tumor specimens.

^* Lv, Zhang and Hu contributed equally in this manuscript as the co-first authors

• References

• 1 Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature reviews Cancer 2003; 3: 422-433
• 2 Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001; 411: 375-379
• 3 Mueller MM, Fusenig NE. Friends or foes—bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer 2004; 4: 839-849
• 4 Tomasek JJ, Gabbiani G, Hinz B. et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Reviews Molecular Cell Biology 2002; 3: 349-363
• 5 Rettig WJ, Garin-Chesa P, Healey JH. et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer research 1993; 53: 3327-3335
• 6 Sugimoto H, Mundel TM, Kieran MW. et al. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biology & Therapy 2006; 5: 1640
• 7 Orimo A, Gupta PB, Sgroi DC. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348
• 8 Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577
• 9 Trimboli AJ, Cantemir-Stone CZ, Li F. et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084-1091
• 10 Montesano R, Vassalli JD, Baird A. et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proceedings of the National Academy of Sciences of the United States of America 1986; 83: 7297-7301
• 11 Gaggioli C, Hooper S, Hidalgo-Carcedo C. et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature cell biology 2007; 9: 1392-1400
• 12 Kalluri R, Zeisberg M. Fibroblasts in cancer. Nature Reviews Cancer 2006; 6: 392
• 13 Ozdemir BC, Pentcheva-Hoang T, Carstens JL. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014; 25: 719-734
• 14 Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nature reviews Cancer 2009; 9: 239-252
• 15 De Wever O, Demetter P, Mareel M. et al. Stromal myofibroblasts are drivers of invasive cancer growth. International journal of cancer 2008; 123: 2229-2238
• 16 Sanchez-Ortiga R, Sanchez-Tejada L, Moreno-Perez O. et al. Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence. Pituitary 2013; 16: 370-377
• 17 Micko AS, Wohrer A, Wolfsberger S. et al. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. Journal of neurosurgery 2015; 122: 803-811
• 18 Shan T, Chen S, Chen X. et al. Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism. Oncology reports 2017; 37: 1971-1979
• 19 Chen HN, Yuan K, Xie N. et al. PDLIM1 stabilizes the E-cadherin/β-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells. Cancer research 2016; 76: 1122
• 20 Taddei ML, Giannoni E, Comito G. et al. Microenvironment and tumor cell plasticity: An easy way out. Cancer letters 2013; 341: 80-96
• 21 Olumi AF, Grossfeld GD, Hayward SW. et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium. Breast Cancer Research 2000; 2: S.19
• 22 Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harbor Perspectives in Biology 2010; 2: a003244
• 23 Schor SL, Schor AM, Rushton G. et al. Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during foetal development. Journal of Cell Science 1985; 73: 221
• 24 Hinz B, Phan SH, Thannickal VJ. et al. The myofibroblast: One function, multiple origins. American Journal of Pathology 2007; 170: 1807
• 25 Viski C, Konig C, Kijewska M. et al. Endosialin-expressing pericytes promote metastatic dissemination. Cancer research 2016; 76: 5313-5325
• 26 Lecoq AL, Viengchareun S, Hage M. et al. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. Endocrine-related cancer 2016; 23: 433-443
• 27 Korsisaari N, Ross J, Wu X. et al. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. Clinical cancer research : an official journal of the American Association for Cancer Research 2008; 14: 249-258
• 28 De WO, Nguyen QD, Van HL. et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. Faseb Journal 2004; 18: 1016-1018
• 29 Banerjee SK, Zoubine MN, Tran TM. et al. Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. International Journal of Oncology 2000; 16: 253-260
• 30 Nishikawa R, Cheng SY, Nagashima R. et al. Expression of vascular endothelial growth factor in human brain tumors. Acta neuropathologica 1998; 96: 453
• 31 Jia W, Sander AJ, Jia G. et al. Vascular endothelial growth inhibitor (VEGI) is an independent indicator for invasion in human pituitary adenomas. Anticancer Research 2013; 33: 3815
• 32 Shimoda Y, Ogawa Y, Watanabe M. et al. Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistochemically negative pituitary adenoma–possible involvement in tumor aggressiveness. Endocrine Research 2013; 38: 242